GI
SCPH

GAMMA Investing’s scPharmaceuticals SCPH Stock Holding History

GAMMA Investing’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-265
Closed -$1.21K – 3822
2024
Q3 		$1.21K Buy
265
+164
+162% +$793 ﹤0.01% 3207
2024
Q2 		$439 Sell
101
-732
-88% -$3.22K ﹤0.01% 3231
2024
Q1 		$4.18K Buy
833
+21
+3% +$118 ﹤0.01% 2482
2023
Q4 		$3.98K Buy
+812
New +$4.65K ﹤0.01% 2335

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

GAMMA Investing's SCPH Position: Q4 2024 in Review

GAMMA Investing sold out of scPharmaceuticals (SCPH) in Q4 2024, closing a stake of 265 shares — an estimated $1.21K sold.

GAMMA Investing first reported a position in SCPH in Q4 2023 and held it in 4 quarters. The position peaked at $4.18K in Q1 2024. 85 funds tracked by Wall St. Rank hold SCPH as of Q4 2024.

  • GAMMA Investing reported no remaining scPharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • GAMMA Investing sold 265 scPharmaceuticals shares in Q4 2024, an estimated $1.21K.
  • GAMMA Investing first reported a position in scPharmaceuticals in Q4 2023 and held it in 4 quarters.
  • GAMMA Investing's scPharmaceuticals position peaked at $4.18K in Q1 2024.
  • 85 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2024.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.